Surgical Staplers Market

The surgical staplers market is projected to reach USD 7.29 billion by 2029 from USD 5.15 billion in 2024 at a CAGR of 7.2% during the forecast period. The leading factor in the demand for advanced surgical stapling devices is the worldwide rise in surgeries, especially MIS. Minimally invasive procedures are preferred over open surgery because they incur shorter recovery times and cause less pain as well as scarring. For MIS, precision and efficiency are crucial parameters to minimize intraoperative complications and for achieving the best result. Surgical stapling instruments, created for such applications, feature secure, consistent tissue closure to enable safer, quicker surgery. Laparoscopic abdominal, gynecologic, and thoracic surgical operations rely on staplers to accurately close incisions and resect tissues. It is advanced with more sophisticated tools, relating to the reloadable units and powered staplers, providing the best possible surgical precision while minimizing the time used in operation. It is driven by a growing number of lifestyle conditions that need surgical treatment, such as gastrointestinal ailments and obesity. Industry majors are investing in R&D to make stapling devices which are better suited for complex MIS procedures, thereby ensuring that the product is flexible and reliable. These factors, therefore, cause a direct boost in the growth prospects for novel surgical stapling devices, thus fueling further growth in the markets. Surgical staplers, particularly advanced powered staplers, are costly, which limits their accessibility in developing countries and among smaller healthcare providers. This may restrain market growth.

In this report, the surgical staplers market has been segmented on the basis of type, technology, usability, application, end user and region.

Prominent players in this market include Medtronic Plc (Ireland), Johnson & Johnson (Ethicon, Inc.) (US), Lepu Medical Technology (Beijing) Co.,Ltd. (China), Intuitive Surgical Inc (US), 3M Company (US), CONMED Corporation (US), B. Braun SE (Germany), Smith+Nephew (UK), Welfare Medical Ltd. (UK), Reach Surgical (China), Meril Life Sciences Pvt Ltd. (India), XNY Medical (China), Purple Surgical (UK), Frankenman International Ltd. (China), Lexington Medical (US), Ningbo Verykind Medical Device Co., Ltd (China), Waston Medical Corporation (China), Suture Planet (India), Dolphin Suture (India), Touchstone International Medical Science Co. Ltd. (China), NewGen Surgical (US), Edges Medicare Private Limited (India), Golden Stapler Surgical Co., Ltd., (China), Victor Medical Instruments Co., Ltd. (China), and Volkmann Medizintechnik GmbH (Germany).

To know about the assumptions considered for the study download the pdf brochure

Medtronic Plc (Ireland)

It operates in high-turbulence markets driven by fast-paced technology advances that call for continued product development improvements and innovation to sustain leadership in the market. R&D efforts at Medtronic Plc are strictly aligned with the objective of attaining technological superiority to guarantee patients receive the most up-to-date, effective forms of treatment. It embraces strategies for the amelioration and expansion of the uses of products, new therapies, and third-party cooperation in co-funding the advancement of technology based on innovation, productivity, and clinical needs to support the improvement in patients' care and establish a new level of care. In May 2024, Covidien Japan, Inc., a subsidiary of Medtronic, entered into a service agreement with HOGY Medical Co., Ltd. to market, together, SureFinD, a marking device for lung cancer patients. When used with Medtronic Covidien's Endo GIA Surgical Stapler, the aim is to provides a holistic approach to resection of the lesion.

Johnson & Johnson (Ethicon, Inc.) (US)

Ethicon leverages the global infrastructure of Johnson & Johnson to sell its wares while availing itself of symbiotic benefits of shared resources in R&D, technological know-how, strategic initiatives, and project execution. Such critical R&D activities are carried out through innovation centers located in Somerville and Cincinnati, U.S., Norderstedt, Germany, and Suzhou, China. Ethicon closely collaborates with surgeons on new product development; in particular, it launched the ECHELON LINEAR Cutter with 3D-Stapling Technology and Gripping Surface Technology (GST) last May for better staple line security. Ethicon boasts strong representations in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with high investments in R&D and sales, especially in emerging economies.

Lepu Medical Technology (Beijing) Co.,Ltd. (China)

Lepu emphasizes cost-effective innovation in its products. They design advanced, but low-cost solutions, customized for the growing markets, where cost can be a critical factor. The company has also invested heavily on R&D so as to develop safe and user-friendly products which are on a par with international standards, yet meeting local requirements. In 2023 Lepu invested USD 124 mln in R&D. It has developed wide distribution networks around Asia and, indeed, gone into international markets but only through partnership and collaboration for its spreading and strengthening global presence.

Related Reports:

Surgical Staplers Market by Type (Linear, Circular, Skin, Curved), Technology (Manual, Powered), Usability (Disposable, Reusable), Application (Abdominal & Pelvic Surgery, General Surgery, Orthopedic Surgery), End User (Hospitals) - Global Forecast to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]